LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | LDN-193189 | 10.0 | uM | LJP5 | 72 | hr | 513 | 132 | 10401 | 0.0127 | -0.0385 |
MCF 10A | Dasatinib | 10.0 | uM | LJP6 | 72 | hr | 513 | 217 | 10401 | 0.0209 | -0.0300 |
MCF 10A | Canertinib | 10.0 | uM | LJP6 | 72 | hr | 513 | 223 | 10401 | 0.0215 | -0.0293 |
MCF 10A | HG-6-64-01 | 10.0 | uM | LJP6 | 72 | hr | 513 | 246 | 10401 | 0.0237 | -0.0270 |
MCF 10A | Geldanamycin | 10.0 | uM | LJP6 | 72 | hr | 513 | 262 | 10401 | 0.0252 | -0.0254 |
MCF 10A | GSK1059615 | 10.0 | uM | LJP5 | 72 | hr | 513 | 283 | 10401 | 0.0272 | -0.0233 |
MCF 10A | Dasatinib | 3.33 | uM | LJP6 | 72 | hr | 513 | 305 | 10401 | 0.0293 | -0.0211 |
MCF 10A | Geldanamycin | 10.0 | uM | LJP5 | 72 | hr | 513 | 307 | 10401 | 0.0296 | -0.0208 |
MCF 10A | GSK1059615 | 10.0 | uM | LJP6 | 72 | hr | 513 | 317 | 10401 | 0.0305 | -0.0199 |
MCF 10A | Withaferin A | 10.0 | uM | LJP5 | 72 | hr | 513 | 321 | 10401 | 0.0309 | -0.0194 |
MCF 10A | Withaferin A | 10.0 | uM | LJP6 | 72 | hr | 513 | 325 | 10401 | 0.0312 | -0.0191 |
MCF 10A | Buparlisib | 10.0 | uM | LJP5 | 72 | hr | 513 | 331 | 10401 | 0.0319 | -0.0184 |
MCF 10A | Dasatinib | 10.0 | uM | LJP5 | 72 | hr | 513 | 332 | 10401 | 0.0320 | -0.0183 |
MCF 10A | Dasatinib | 3.33 | uM | LJP5 | 72 | hr | 513 | 337 | 10401 | 0.0324 | -0.0178 |
MCF 10A | Withaferin A | 3.33 | uM | LJP6 | 72 | hr | 513 | 345 | 10401 | 0.0332 | -0.0170 |
MCF 10A | Radicicol | 10.0 | uM | LJP5 | 72 | hr | 513 | 347 | 10401 | 0.0334 | -0.0168 |
MCF 10A | GSK1059615 | 3.33 | uM | LJP5 | 72 | hr | 513 | 348 | 10401 | 0.0335 | -0.0167 |
MCF 10A | A443654 | 3.33 | uM | LJP6 | 72 | hr | 513 | 351 | 10401 | 0.0338 | -0.0164 |
MCF 10A | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 513 | 351 | 10401 | 0.0338 | -0.0164 |
MCF 10A | AZD7762 | 10.0 | uM | LJP6 | 72 | hr | 513 | 353 | 10401 | 0.0340 | -0.0162 |
MCF 10A | QL-X-138 | 10.0 | uM | LJP6 | 72 | hr | 513 | 363 | 10401 | 0.0349 | -0.0152 |
MCF 10A | Mitoxantrone | 3.33 | uM | LJP5 | 72 | hr | 513 | 371 | 10401 | 0.0357 | -0.0144 |
MCF 10A | Withaferin A | 3.33 | uM | LJP5 | 72 | hr | 513 | 374 | 10401 | 0.0360 | -0.0140 |
MCF 10A | TWS119 | 10.0 | uM | LJP5 | 72 | hr | 513 | 385 | 10401 | 0.0371 | -0.0129 |
MCF 10A | Buparlisib | 3.33 | uM | LJP5 | 72 | hr | 513 | 386 | 10401 | 0.0371 | -0.0129 |